- Home
- ARVN vs BBCP Comparison
ARVN vs BBCP Comparison
Compare ARVN & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- BBCP
- Stock Information
- Founded
- ARVN 2015
- BBCP 1983
- Country
- ARVN United States
- BBCP United States
- Employees
- ARVN N/A
- BBCP N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- BBCP Engineering & Construction
- Sector
- ARVN Health Care
- BBCP Consumer Discretionary
- Exchange
- ARVN Nasdaq
- BBCP Nasdaq
- Market Cap
- ARVN 456.2M
- BBCP 387.3M
- IPO Year
- ARVN 2018
- BBCP 2017
- Fundamental
- Price
- ARVN $7.53
- BBCP $6.07
- Analyst Decision
- ARVN Buy
- BBCP Buy
- Analyst Count
- ARVN 21
- BBCP 4
- Target Price
- ARVN $20.53
- BBCP $7.67
- AVG Volume (30 Days)
- ARVN 2.2M
- BBCP 85.6K
- Earning Date
- ARVN 07-29-2025
- BBCP 06-05-2025
- Dividend Yield
- ARVN N/A
- BBCP N/A
- EPS Growth
- ARVN N/A
- BBCP N/A
- EPS
- ARVN N/A
- BBCP 0.23
- Revenue
- ARVN $426,900,000.00
- BBCP $401,503,000.00
- Revenue This Year
- ARVN $2.83
- BBCP N/A
- Revenue Next Year
- ARVN N/A
- BBCP $6.18
- P/E Ratio
- ARVN N/A
- BBCP $26.48
- Revenue Growth
- ARVN 498.74
- BBCP N/A
- 52 Week Low
- ARVN $5.90
- BBCP $4.78
- 52 Week High
- ARVN $34.11
- BBCP $9.68
- Technical
- Relative Strength Index (RSI)
- ARVN 54.38
- BBCP 32.90
- Support Level
- ARVN $6.70
- BBCP $6.87
- Resistance Level
- ARVN $7.60
- BBCP $7.27
- Average True Range (ATR)
- ARVN 0.45
- BBCP 0.23
- MACD
- ARVN 0.15
- BBCP -0.11
- Stochastic Oscillator
- ARVN 95.04
- BBCP 21.76
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.